CT Private Equity Trust PLC
CTPE.L
London Stock Exchange- -
GBp
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- CT Private Equity Trust PLC (CTPE.L) is a closed-end investment company listed on the London Stock Exchange that provides investors with exposure to a diversified portfolio of private equity funds and direct co-investments in unlisted private businesses, targeting medium- to long-term capital growth. The Trust's investments span lower mid-market opportunities across the UK, Europe, and North America, including commitments to private equity funds such as August Equity VI, Inflexion Enterprise Fund VI, and ARCHIMED MED Rise, as well as direct stakes in companies like Accounts IQ, Breeze Group, and MedSpa. Managed by Columbia Threadneedle Investments since the evolution from its prior affiliations with F&C and BMO, with Hamish Mair as lead manager since 2000, the company maintains a portfolio diversified across sectors and geographies to mitigate risk while pursuing high-quality assets. Founded in 1999 and headquartered in Edinburgh, Scotland, CT Private Equity Trust PLC operates primarily in the United Kingdom with a domicile there and focuses on institutional-grade private equity typically inaccessible to retail investors. The portfolio includes both primary fund commitments and secondary investments, alongside selective direct co-investments, supported by net gearing of around 12% and outstanding undrawn commitments of approximately £178 million as of mid-2025. The Trust celebrated its 25th anniversary in 2024, marking a milestone with a ceremonial closing bell at the London Stock Exchange. Recent developments include a 76% surge in realisations to £108.6 million for the year ended December 31, 2024, reflecting improved exit activity in private markets, alongside new investments totaling £58.7 million. In 2024, the company revised its loan agreement, expanding the term loan with RBS International to £60 million and extending the overall facility maturity to February 2027. For the first half of 2025, the Trust reported a net asset value per share of 674.16 pence amid foreign exchange headwinds and delayed valuations, while expressing confidence in second-half gains from recovering deal activity; third-quarter 2025 results announced further dividend declarations and noted the planned retirement of Chairman Richard Gray. Portfolio uplifts were recorded in holdings such as Inflexion Strategic Partners, Utimaco, Habitus, and CARDO Group, alongside funds like Axiom I and Bencis V.